Markers of anti-oxidant response in tobacco smoke exposed subjects: A data-mining review

Pulmonary Pharmacology and Therapeutics

Volumn 23, Issue 6, 2010, Pages 482-492

  Comandini, Alessia ^a   Marzano, Valeria ^a,b   Curradi, Giacomo ^a   Federici, Giorgio ^a,c   Urbani, Andrea ^a,b   Saltini, Cesare ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Chronic obstructive pulmonary disease; Mitochondrial dysfunction; Nrf2; Oxidative stress; Tobacco smoke

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; TOBACCO SMOKE; TRANSCRIPTION FACTOR NRF2;

ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DATA MINING; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; EMPHYSEMA; GENOMICS; HUMAN; INFLAMMATION; LUNG INJURY; LUNG LAVAGE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; STATISTICAL SIGNIFICANCE; UPREGULATION;

ANTIOXIDANTS; BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; DATA MINING; GENE EXPRESSION REGULATION; HUMANS; LUNG; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKE; SMOKING; TOBACCO;

EID: 78649319046     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.05.006     Document Type: Article

References (57)

1. Steele M.P., Speer M.C., Loyd J.E., Brown K.K., Herron A., Slifer S.H., et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005, 172(9):1146-1152.
2. Geneva, World Health Organization. WHO Report on the global tobacco epidemic, 2008: The MPOWER package; 2008.
3. The surgeon general's 1989 report on reducing the health consequences of smoking: 25 years of progress. MMWR Morb Mortal Wkly Rep 1989, 38(Suppl. 2):1-32.
4. Mannino D.M., Buist A.S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370(9589):765-773.
5. Lopez A.D., Shibuya K., Rao C., Mathers C.D., Hansell A.L., Held L.S., et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006, 27(2):397-412.
6. Macnee W. Pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med 2007, 28(3):479-513. v.
7. Mannino D.M., Gagnon R.C., Petty T.L., Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000, 160(11):1683-1689.
8. Cazzola M., MacNee W., Martinez F.J., Rabe K.F., Franciosi L.G., Barnes P.J., et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008, 31(2):416-469.
9. Franciosi L.G., Page C.P., Celli B.R., Cazzola M., Walker M.J., Danhof M., et al. Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2006, 19(3):189-199.
10. Dekhuijzen P.N., Aben K.K., Dekker I., Aarts L.P., Wielders P.L., van Herwaarden C.L., et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996, 154(3 Pt 1):813-816.
11. Montuschi P., Collins J.V., Ciabattoni G., Lazzeri N., Corradi M., Kharitonov S.A., et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000, 162(3 Pt 1):1175-1177.
12. Kim S.H., Ensunsa J.L., Zhu Q.Y., Kim J.S., Shin H.S., Keen C.L. An 18-month follow-up study on the influence of smoking on blood antioxidant status of teenage girls in comparison with adult male smokers in Korea. Nutrition 2004, 20(5):437-444.
13. DiSilvestro R.A., Pacht E., Davis W.B., Jarjour N., Joung H., Trela-Fulop K. BAL fluid contains detectable superoxide dismutase 1 activity. Chest 1998, 113(2):401-404.
14. Comandini A., Rogliani P., Nunziata A., Cazzola M., Curradi G., Saltini C. Biomarkers of lung damage associated with tobacco smoke in induced sputum. Respir Med 2009, 103(11):1592-1613.
15. Maglott D., Ostell J., Pruitt K.D., Tatusova T. Entrez gene: gene-centered information at NCBI. Nucleic Acids Res 2005, 33(Database issue):D54-D58.
16. ® systems http://www.ingenuity.com.
17. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 1995, 57:289-300.
18. Heguy A., O'Connor T.P., Luettich K., Worgall S., Cieciuch A., Harvey B.G., et al. Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med 2006, 84(4):318-328.
19. Beane J., Sebastiani P., Liu G., Brody J.S., Lenburg M.E., Spira A. Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol 2007, 8(9):R201.
20. Spira A., Beane J., Shah V., Liu G., Schembri F., Yang X., et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci U S A 2004, 101(27):10143-10148.
21. Harvey B., Heguy A., Leopold P.L., Carolan B.J., Ferris B., Crystal R.G. Modification of gene expression of the small airway epithelium in response to cigarette smoking. J Mol Med 2007, 85(1):39-53.
22. Chari R., Lonergan K.M., Ng R.T., MacAulay C., Lam W.L., Lam S. Effect of active smoking on the human bronchial epithelium transcriptome. BMC Genomics 2007, 8:297.
23. Ning W., Li C., Kaminski N., Feghali-Bostwick C.A., Alber S.M., Di Y.P., et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A 2004, 101(41):14895-14900.
24. Kelsen S.G., Duan X., Ji R., Perez O., Liu C., Merali S. Cigarette smoke induces an unfolded protein response in the human lung: a proteomic approach. Am J Respir Cell Mol Biol 2008, 38(5):541-550.
25. Merkel D., Rist W., Seither P., Weith A., Lenter M.C. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification. Proteomics 2005, 5(11):2972-2980.
26. Yao H., Yang S., Kode A., Rajendrasozhan S., Caito S., Adenuga D., et al. Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling. Biochem Soc Trans 2007, 35(Pt 5):1151-1155.
27. Barnes P.J. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009, 6(8):693-696.
28. MacNee W. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). Biochem Soc Trans 2009, 37(Pt 4):819-823.
29. Ito K., Barnes P.J. COPD as a disease of accelerated lung aging. Chest 2009, 135(1):173-180.
30. Hulea S.A., Olinescu R., Nitã S., Crocnan D., Kummerow F.A. Cigarette smoking causes biochemical changes in blood that are suggestive of oxidative stress: a case-control study. J Environ Pathol Toxicol Oncol 1995, 14(3-4):173-180.
31. Suzuki M., Betsuyaku T., Ito Y., Nagai K., Nasuhara Y., Kaga K., et al. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2008, 39(6):673-682.
32. Nguyen T., Sherratt P.J., Pickett C.B. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 2003, 43:233-260.
33. Jeong W., Jun M., Kong A.T. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 2006, 8(1-2):99-106.
34. Malhotra D., Thimmulappa R., Navas-Acien A., Sandford A., Elliott M., Singh A., et al. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med 2008, 178(6):592-604.
35. Goven D., Boutten A., Leçon-Malas V., Marchal-Sommé J., Amara N., Crestani B., et al. Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema. Thorax 2008, 63(10):916-924.
36. Hübner R., Schwartz J.D., De Bishnu P., Ferris B., Omberg L., Mezey J.G., et al. Coordinate control of expression of Nrf2-modulated genes in the human small airway epithelium is highly responsive to cigarette smoking. Mol Med 2009, 15(7-8):203-219.
37. Hackett N.R., Heguy A., Harvey B., O'Connor T.P., Luettich K., Flieder D.B., et al. Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Biol 2003, 29(3 Pt 1):331-343.
38. Plymoth A., Löfdahl C., Ekberg-Jansson A., Dahlbäck M., Broberg P., Foster M., et al. Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers. Clin Chem 2007, 53(4):636-644.
39. Plymoth A., Yang Z., Löfdahl C., Ekberg-Jansson A., Dahlbäck M., Fehniger T.E., et al. Rapid proteome analysis of bronchoalveolar lavage samples of lifelong smokers and never-smokers by micro-scale liquid chromatography and mass spectrometry. Clin Chem 2006, 52(4):671-679.
40. Thum T., Erpenbeck V.J., Moeller J., Hohlfeld J.M., Krug N., Borlak J. Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ Health Perspect 2006, 114(11):1655-1661.
41. Tomaki M., Sugiura H., Koarai A., Komaki Y., Akita T., Matsumoto T., et al. Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung. Pulm Pharmacol Ther 2007, 20(5):596-605.
42. Maestrelli P., Páska C., Saetta M., Turato G., Nowicki Y., Monti S., et al. Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Eur Respir J 2003, 21(6):971-976.
43. Neurohr C., Lenz A.G., Ding I., Leuchte H., Kolbe T., Behr J. Glutamate-cysteine ligase modulatory subunit in BAL alveolar macrophages of healthy smokers. Eur Respir J 2003, 22(1):82-87.
44. Smith C.A., Harrison D.J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997, 350(9078):630-633.
45. Yamada N., Yamaya M., Okinaga S., Nakayama K., Sekizawa K., Shibahara S., et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000, 66(1):187-195.
46. Harrison D.J., Cantlay A.M., Rae F., Lamb D., Smith C.A. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol 1997, 16(7):356-360.
47. Ishii T., Matsuse T., Teramoto S., Matsui H., Miyao M., Hosoi T., et al. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999, 54(8):693-696.
48. Juul K., Tybjaerg-Hansen A., Marklund S., Lange P., Nordestgaard B.G. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173(8):858-864.
49. Young R.P., Hopkins R., Black P.N., Eddy C., Wu L., Gamble G.D., et al. Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function. Thorax 2006, 61(5):394-399.
50. van der Toorn M., Slebos D., de Bruin H.G., Leuvenink H.G., Bakker S.J., Gans R.O., et al. Cigarette smoke-induced blockade of the mitochondrial respiratory chain switches lung epithelial cell apoptosis into necrosis. Am J Physiol Lung Cell Mol Physiol 2007, 292(5):L1211-L1218.
51. Gruys E., Toussaint M.J.M., Niewold T.A., Koopmans S.J. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 2005, 6(11):1045-1056.
52. Hogg J.C., Eeden S.V. Pulmonary and systemic response to atmospheric pollution. Respirology 2009, 14(3):336-346.
53. Barnes P.J. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004, 56(4):515-548.
54. Chung K.F. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001, 34:50s-59s.
55. Owen C.A. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008, 3(2):253-268.
56. Nakayama K., Kikuchi A., Yasuda H., Ebihara S., Sasaki T., Ebihara T., et al. Heme oxygenase-1 gene promoter polymorphism and decline in lung function in Japanese men. Thorax 2006, 61(10):921.
57. Guénégou A., Leynaert B., Bénessiano J., Pin I., Demoly P., Neukirch F., et al. Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France. J Med Genet 2006, 43(8):e43.